{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["angiogenesis", "maslinic acid", "proliferating cell nuclear antigen", "renal cell carcinoma", "vascular endothelial growth factor"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "28405545", "DateRevised": {"Year": "2020", "Month": "09", "Day": "30"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "03", "Day": "21"}], "Language": ["eng"], "ELocationID": ["10.15586/jkcvhl.2017.64"], "Journal": {"ISSN": "2203-5826", "JournalIssue": {"Volume": "4", "Issue": "1", "PubDate": {"Year": "2017"}}, "Title": "Journal of kidney cancer and VHL", "ISOAbbreviation": "J Kidney Cancer VHL"}, "ArticleTitle": "Maslinic Acid Inhibits Proliferation of Renal Cell Carcinoma Cell Lines and Suppresses Angiogenesis of Endothelial Cells.", "Pagination": {"StartPage": "16", "EndPage": "24", "MedlinePgn": "16-24"}, "Abstract": {"AbstractText": ["Despite the introduction of many novel therapeutics in clinical practice, metastatic renal cell carcinoma (RCC) remains a treatment-resistant cancer. As red and processed meat are considered risk factors for RCC, and a vegetable-rich diet is thought to reduce this risk, research into plant-based therapeutics may provide valuable complementary or alternative therapeutics for the management of RCC. Herein, we present the antiproliferative and antiangiogenic effects of maslinic acid, which occurs naturally in edible plants, particularly in olive fruits, and also in a variety of medicinal plants. Human RCC cell lines (ACHN, Caki-1, and SN12K1), endothelial cells (human umbilical vein endothelial cell line [HUVEC]), and primary cultures of kidney proximal tubular epithelial cells (PTEC) were treated with maslinic acid. Maslinic acid was relatively less toxic to PTEC when compared with RCC under similar experimental conditions. In RCC cell lines, maslinic acid induced a significant reduction in proliferation, proliferating cell nuclear antigen, and colony formation. In HUVEC, maslinic acid induced a significant reduction in capillary tube formation in vitro and vascular endothelial growth factor. This study provides a rationale for incorporating a maslinic acid-rich diet either to reduce the risk of developing kidney cancer or as an adjunct to existing antiangiogenic therapy to improve efficacy."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Kidney Disease Research, School of Medicine, Translational Research Institute, The University of Queensland, Brisbane, Queensland, Australia; Department of General Surgery, Affiliated Hospital to Xuzhou Medical University, Xuzhou, China; B. R. D. School of Biosciences, Sardar Patel University, Vallabhvidyanagar, Gujarat, India; Department of Renal Medicine, The University of Queensland at Princess Alexandra Hospital, Brisbane, Queensland, Australia."}], "LastName": "Thakor", "ForeName": "Parth", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Kidney Disease Research, School of Medicine, Translational Research Institute, The University of Queensland, Brisbane, Queensland, Australia; Department of General Surgery, Affiliated Hospital to Xuzhou Medical University, Xuzhou, China; B. R. D. School of Biosciences, Sardar Patel University, Vallabhvidyanagar, Gujarat, India; Department of Renal Medicine, The University of Queensland at Princess Alexandra Hospital, Brisbane, Queensland, Australia."}], "LastName": "Song", "ForeName": "Wenzhe", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Kidney Disease Research, School of Medicine, Translational Research Institute, The University of Queensland, Brisbane, Queensland, Australia; Department of General Surgery, Affiliated Hospital to Xuzhou Medical University, Xuzhou, China; B. R. D. School of Biosciences, Sardar Patel University, Vallabhvidyanagar, Gujarat, India; Department of Renal Medicine, The University of Queensland at Princess Alexandra Hospital, Brisbane, Queensland, Australia."}], "LastName": "Subramanian", "ForeName": "Ramalingam B", "Initials": "RB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Kidney Disease Research, School of Medicine, Translational Research Institute, The University of Queensland, Brisbane, Queensland, Australia; Department of General Surgery, Affiliated Hospital to Xuzhou Medical University, Xuzhou, China; B. R. D. School of Biosciences, Sardar Patel University, Vallabhvidyanagar, Gujarat, India; Department of Renal Medicine, The University of Queensland at Princess Alexandra Hospital, Brisbane, Queensland, Australia."}], "LastName": "Thakkar", "ForeName": "Vasudev R", "Initials": "VR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Kidney Disease Research, School of Medicine, Translational Research Institute, The University of Queensland, Brisbane, Queensland, Australia; Department of General Surgery, Affiliated Hospital to Xuzhou Medical University, Xuzhou, China; B. R. D. School of Biosciences, Sardar Patel University, Vallabhvidyanagar, Gujarat, India; Department of Renal Medicine, The University of Queensland at Princess Alexandra Hospital, Brisbane, Queensland, Australia."}], "LastName": "Vesey", "ForeName": "David A", "Initials": "DA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Kidney Disease Research, School of Medicine, Translational Research Institute, The University of Queensland, Brisbane, Queensland, Australia; Department of General Surgery, Affiliated Hospital to Xuzhou Medical University, Xuzhou, China; B. R. D. School of Biosciences, Sardar Patel University, Vallabhvidyanagar, Gujarat, India; Department of Renal Medicine, The University of Queensland at Princess Alexandra Hospital, Brisbane, Queensland, Australia."}], "LastName": "Gobe", "ForeName": "Glenda C", "Initials": "GC"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Australia", "MedlineTA": "J Kidney Cancer VHL", "NlmUniqueID": "101695919", "ISSNLinking": "2203-5826"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Soerensen AV, Donskov F, Hermann GG, Jensen NV, Petersen A, Spliid H, et al.  Improved overall survival after implementation of targeted therapy for patients with metastatic renal cell carcinoma: results from the Danish Renal Cancer Group (DARENCA) study-2. Eur J Cancer. 2014;50(3):553\u201362.  http://dx.doi.org/10.1016/j.ejca.2013.10.010.", "ArticleIdList": ["10.1016/j.ejca.2013.10.010", "24215846"]}, {"Citation": "Koshkin VS, Rini BI. Emerging therapeutics in refractory renal cell carcinoma. Expert Opin Pharmacother. 2016;17(9):1225\u201332.  http://dx.doi.org/10.1080/14656566.2016.1182987.", "ArticleIdList": ["10.1080/14656566.2016.1182987", "27112171"]}, {"Citation": "Jim\u00e9nez-Valerio G, Mart\u00ednez-Lozano M, Bassani N, Vidal A, Ochoa-de-Olza M, Su\u00e1rez C, et al.  Resistance to antiangiogenic therapies by metabolic symbiosis in renal cell carcinoma PDX models and patients. Cell Rep. 2016;15(6):1134\u201343.  http://dx.doi.org/10.1016/j.celrep.2016.04.015.", "ArticleIdList": ["10.1016/j.celrep.2016.04.015", "PMC4870515", "27134180"]}, {"Citation": "Lim SH, Hwang IG, Ji JH, Oh SY, Yi JH, Lim DH, et al.  Intrinsic resistance to sunitinib in patients with metastatic renal cell carcinoma. Asia Pac J Clin Oncol. 2017;13(1):61\u201367.  http://dx.doi.org/10.1111/ajco.12465.", "ArticleIdList": ["10.1111/ajco.12465", "27030134"]}, {"Citation": "Rini BI, Atkins MB. Resistance to targeted therapy in renal-cell carcinoma. Lancet Oncol. 2009;10(10):992\u20131000.  http://dx.doi.org/10.1016/S1470-2045(09)70240-2.", "ArticleIdList": ["10.1016/S1470-2045(09)70240-2", "19796751"]}, {"Citation": "Porta C, Sabbatini R, Procopio G, Paglino C, Galligioni E, Ortega C. Primary resistance to tyrosine kinase inhibitors in patients with advanced renal cell carcinoma: state-of-the-science. Expert Rev Anticancer Ther. 2012;12(12):1571\u20137.  http://dx.doi.org/10.1586/era.12.81.", "ArticleIdList": ["10.1586/era.12.81", "23181412"]}, {"Citation": "Busch J, Seidel C, Weikert S, Wolff I, Kempkensteffen C, Weinkauf L, et al.  Intrinsic resistance to tyrosine kinase inhibitors is associated with poor clinical outcome in metastatic renal cell carcinoma. BMC Cancer. 2011;11:295.  http://dx.doi.org/10.1186/1471-2407-11-295.", "ArticleIdList": ["10.1186/1471-2407-11-295", "PMC3154177", "21756335"]}, {"Citation": "Amin A, Gali-Muhtasib H, Ocker M, Schneider-Stock R. Overview of major classes of plant-derived anticancer drugs. Int J Biomed Sci. 2009;5(1):1\u201311.", "ArticleIdList": ["PMC3614754", "23675107"]}, {"Citation": "Joshi M, Liu X, Belani CP. Taxanes, past, present, and future impact on non-small cell lung cancer. Anticancer Drugs. 2014;25(5):571\u201383.  http://dx.doi.org/10.1097/CAD.0000000000000080.", "ArticleIdList": ["10.1097/CAD.0000000000000080", "24463482"]}, {"Citation": "Rohrmann S, Linseisen J, Overvad K, Lund W\u00fcrtz AM, Roswall N, Tjonneland A, et al.  Meat and fish consumption and the risk of renal cell carcinoma in the European prospective investigation into cancer and nutrition. Int J Cancer. 2015;136(5):E423\u201331.  http://dx.doi.org/10.1002/ijc.29236.", "ArticleIdList": ["10.1002/ijc.29236", "25258006"]}, {"Citation": "Daniel CR, Schwartz KL, Colt JS, Dong LM. Meat-cooking mutagens and risk of renal cell carcinoma. Br J Cancer. 2011;105(7):1096\u2013104.  http://dx.doi.org/10.1038/bjc.2011.343.", "ArticleIdList": ["10.1038/bjc.2011.343", "PMC3185955", "21897389"]}, {"Citation": "Hsu CC, Chow WH, Boffetta P, Moore L, Zaridze D, Moukeria A, et al.  Dietary risk factors for kidney cancer in Eastern and Central Europe. Am J Epidemiol. 2007;166(1):62\u201370.  http://dx.doi.org/10.1093/aje/kwm043.", "ArticleIdList": ["10.1093/aje/kwm043", "17456477"]}, {"Citation": "Grieb SM, Theis RP, Burr D, Benardot D, Siddiqui T, Asal NR. Food groups and renal cell carcinoma: results from a case-control study. J Am Diet Assoc. 2009;109(4):656\u201367.  http://dx.doi.org/10.1016/j.jada.2008.12.020.", "ArticleIdList": ["10.1016/j.jada.2008.12.020", "19328261"]}, {"Citation": "Rashidkhani B, Lindblad P, Wolk A. Fruits, vegetables and risk of renal cell carcinoma: a prospective study of Swedish women. Int J Cancer. 2005;113(3):451\u20135.  http://dx.doi.org/10.1002/ijc.20577.", "ArticleIdList": ["10.1002/ijc.20577", "15455348"]}, {"Citation": "Reyes-Zurita FJ, Rufino-Palomares EE, Lupianez JA, Cascante M. Maslinic acid, a natural triterpene from Olea europaea L., induces apoptosis in HT29 human colon-cancer cells via the mitochondrial apoptotic pathway. Cancer Lett. 2009;273(1):44\u201354.  http://dx.doi.org/10.1016/j.canlet.2008.07.033.", "ArticleIdList": ["10.1016/j.canlet.2008.07.033", "18790561"]}, {"Citation": "Lozano-Mena G, Sanchez-Gonzalez M, Juan ME, Planas JM. Maslinic acid, a natural phytoalexin-type triterpene from olives\u2013a promising nutraceutical? Molecules. 2014;19(8):11538\u201359.  http://dx.doi.org/10.3390/molecules190811538.", "ArticleIdList": ["10.3390/molecules190811538", "PMC6271970", "25093990"]}, {"Citation": "Montilla MP, Agil A, Navarro MC, Jim\u00e9nez MI, Garc\u00eda-Granados A, Parra A, et al.  Antioxidant activity of maslinic acid, a triterpene derivative obtained from Olea europaea. Planta Med. 2003;69(5):472\u20134.  http://dx.doi.org/10.1055/s-2003-39698.", "ArticleIdList": ["10.1055/s-2003-39698", "12802735"]}, {"Citation": "Huang L, Guan T, Qian Y, Huang M, Tang X, Li Y, et al.  Anti- inflammatory effects of maslinic acid, a natural triterpene, in cultured cortical astrocytes via suppression of nuclear factor-kappa B. Eur J Pharmacol. 2011;672(1\u20133):169\u201374.  http://dx.doi.org/10.1016/j.ejphar.2011.09.175.", "ArticleIdList": ["10.1016/j.ejphar.2011.09.175", "21970807"]}, {"Citation": "Moneriz C, Mestres J, Bautista JM, Diez A, Puyet A. Multi-targeted activity of maslinic acid as an antimalarial natural compound. FEBS J. 2011;278(16):2951\u201361.  http://dx.doi.org/10.1111/j.1742-4658.2011.08220.x.", "ArticleIdList": ["10.1111/j.1742-4658.2011.08220.x", "21689375"]}, {"Citation": "De Pablos LM, Gonz\u00e1lez G, Rodrigues R, Garc\u00eda Granados A, Parra A, Osuna A. Action of a pentacyclic triterpenoid, maslinic acid, against Toxoplasma gondii. J Nat Prod. 2010;73(5):831\u20134.  http://dx.doi.org/10.1021/np900749b.", "ArticleIdList": ["10.1021/np900749b", "20441162"]}, {"Citation": "Liu J, Sun H, Duan W, Mu D, Zhang L. Maslinic acid reduces blood glucose in KK-Ay mice. Biol Pharm Bull. 2007;30(11):2075\u20138.  http://dx.doi.org/10.1248/bpb.30.2075.", "ArticleIdList": ["10.1248/bpb.30.2075", "17978478"]}, {"Citation": "Parra A, Rivas F, Lopez PE, Garcia-Granados A, Martinez A, Albericio F, et al.  Solution- and solid-phase synthesis and anti-HIV activity of maslinic acid derivatives containing amino acids and peptides. Bioorg Med Chem. 2009;17(3):1139\u201345.  http://dx.doi.org/10.1016/j.bmc.2008.12.041.", "ArticleIdList": ["10.1016/j.bmc.2008.12.041", "19135380"]}, {"Citation": "Park SY, Nho CW, Kwon DY, Kang YH, Lee KW, Park JH. Maslinic acid inhibits the metastatic capacity of DU145 human prostate cancer cells: possible mediation via hypoxia-inducible factor-1alpha signalling. Br J Nutr. 2013;109(2):210\u201322.  http://dx.doi.org/10.1017/S0007114512000967.", "ArticleIdList": ["10.1017/S0007114512000967", "22716951"]}, {"Citation": "Zhang S, Ding D, Zhang X, Shan L, Liu Z. Maslinic acid induced apoptosis in bladder cancer cells through activating p38 MAPK signaling pathway. Mol Cell Biochem. 2014;392(1\u20132):281\u20137.  http://dx.doi.org/10.1007/s11010-014-2038-y.", "ArticleIdList": ["10.1007/s11010-014-2038-y", "24687305"]}, {"Citation": "Hsia TC, Liu WH, Qiu WW, Luo J, Yin MC. Maslinic acid induces mitochondrial apoptosis and suppresses HIF-1alpha expression in A549 lung cancer cells under normoxic and hypoxic conditions. Molecules. 2014;19(12):19892\u2013906.  http://dx.doi.org/10.3390/molecules191219892.", "ArticleIdList": ["10.3390/molecules191219892", "PMC6271386", "25460312"]}, {"Citation": "Li C, Yang Z, Zhai C, Qiu W, Li D, Yi Z, Wang L, et al.  Maslinic acid potentiates the anti-tumor activity of tumor necrosis factor alpha by inhibiting NF-kappaB signaling pathway. Mol Cancer. 2010;9:73.  http://dx.doi.org/10.1186/1476-4598-9-73.", "ArticleIdList": ["10.1186/1476-4598-9-73", "PMC2907730", "20367887"]}, {"Citation": "Morais C, Westhuyzen J, Pat B, Gobe G, Healy H. High ambient glucose is effect neutral on cell death and proliferation in human proximal tubular epithelial cells. Am J Physiol Renal Physiol. 2005;289(2):F401\u20139.  http://dx.doi.org/10.1152/ajprenal.00408.2004.", "ArticleIdList": ["10.1152/ajprenal.00408.2004", "15827344"]}, {"Citation": "Morais C, Pat B, Gobe G, Johnson DW, Healy H. Pyrrolidine dithiocarbamate exerts anti-proliferative and pro-apoptotic effects in renal cell carcinoma cell lines. Nephrol Dial Transplant. 2006;21(12):3377\u201388.  http://dx.doi.org/10.1093/ndt/gfl543.", "ArticleIdList": ["10.1093/ndt/gfl543", "16998220"]}, {"Citation": "Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26(4):239\u201357.  http://dx.doi.org/10.1038/bjc.1972.33.", "ArticleIdList": ["10.1038/bjc.1972.33", "PMC2008650", "4561027"]}, {"Citation": "Morais C, Gobe G, Johnson DW, Healy H. Anti-angiogenic actions of pyrrolidine dithiocarbamate, a nuclear factor kappa B inhibitor. Angiogenesis. 2009;12(4):365\u201379.  http://dx.doi.org/10.1007/s10456-009-9158-0.", "ArticleIdList": ["10.1007/s10456-009-9158-0", "19882112"]}, {"Citation": "Morais C, Ebrahem Q, Anand-Apte B, Parat MO. Altered angiogenesis in caveolin-1 gene-deficient mice is restored by ablation of endothelial nitric oxide synthase. Am J Pathol. 2012;180(4):1702\u201314.  http://dx.doi.org/10.1016/j.ajpath.2011.12.018.", "ArticleIdList": ["10.1016/j.ajpath.2011.12.018", "PMC5691329", "22322296"]}, {"Citation": "Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374.  http://dx.doi.org/10.1016/j.cell.2011.02.013.", "ArticleIdList": ["10.1016/j.cell.2011.02.013", "21376230"]}, {"Citation": "Nam YJ, Mani K, Ashton AW, Peng CF, Krishnamurthy B, Hayakawa Y, et al.  Inhibition of both the extrinsic and intrinsic death pathways through nonhomotypic death-fold interactions. Mol Cell. 2004;15(6):901\u201312.  http://dx.doi.org/10.1016/j.molcel.2004.08.020.", "ArticleIdList": ["10.1016/j.molcel.2004.08.020", "15383280"]}, {"Citation": "Ola MS, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis. Mol Cell Biochem. 2011;351(1\u20132):41\u201358.  http://dx.doi.org/10.1007/s11010-010-0709-x.", "ArticleIdList": ["10.1007/s11010-010-0709-x", "21210296"]}, {"Citation": "Bai X, Zhang Y, Jiang H, Yang P, Li H, Zhang Y, et al. Effects of maslinic acid on the proliferation and apoptosis of A549 lung cancer cells. Mol Med Rep. 2016;13(1):117\u201322.", "ArticleIdList": ["PMC4686082", "26572558"]}, {"Citation": "Dirim A1, Haberal AN, Goren MR, Tekin MI, Peskircioglu L, Demirhan B, et al.  VEGF, COX-2, and PCNA expression in renal cell carcinoma subtypes and their prognostic value. Int Urol Nephrol. 2008;40(4):861\u20138.  http://dx.doi.org/10.1007/s11255-008-9362-7.", "ArticleIdList": ["10.1007/s11255-008-9362-7", "18324478"]}, {"Citation": "Amare Kadam PS, Varghese C, Bharde SH, Narasimhamoorthy NK, Desai S, Advani SH, et al.  Proliferating cell nuclear antigen and epidermal growth factor receptor (EGFr) status in renal cell carcinoma patients with polysomy of chromosome 7. Cancer Genet Cytogenet. 2001;125(2):139\u201346.  http://dx.doi.org/10.1016/S0165-4608(00)00375-7.", "ArticleIdList": ["10.1016/S0165-4608(00)00375-7", "11369057"]}, {"Citation": "Tang SW, Chang WH, Su YC, Chen YC, Lai YH, Wu PT, et al.  MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells. Cancer Lett. 2009;273(1):35\u201343.  http://dx.doi.org/10.1016/j.canlet.2008.07.038.", "ArticleIdList": ["10.1016/j.canlet.2008.07.038", "18809243"]}, {"Citation": "Rini BI, Small EJ. Biology and clinical development of vascular endothelial growth factor-targeted therapy in renal cell carcinoma. J Clin Oncol. 2005;23(5):1028\u201343.  http://dx.doi.org/10.1200/JCO.2005.01.186.", "ArticleIdList": ["10.1200/JCO.2005.01.186", "15534359"]}, {"Citation": "Posadas EM, Limvorasak S, Sharma S, Figlin RA. Targeting angiogenesis in renal cell carcinoma. Expert Opin Pharmacother. 2013;14(16):2221\u201336.  http://dx.doi.org/10.1517/14656566.2013.832202.", "ArticleIdList": ["10.1517/14656566.2013.832202", "23984807"]}, {"Citation": "Takahashi A, Sasaki H, Kim SJ, Tobisu K, Kakizoe T, Tsukamoto T, et al. Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis. Cancer Res. 1994 Aug 1;54(15):4233\u20137.", "ArticleIdList": ["7518352"]}, {"Citation": "Zhang X, Yamashita M, Uetsuki H, Kakehi Y. Angiogenesis in renal cell carcinoma: Evaluation of microvessel density, vascular endothelial growth factor and matrix metalloproteinases. Int J Urol. 2002;9(9):509\u201314.  http://dx.doi.org/10.1046/j.1442-2042.2002.00511.x.", "ArticleIdList": ["10.1046/j.1442-2042.2002.00511.x", "12410931"]}, {"Citation": "Rioux-Leclercq N, Fergelot P, Zerrouki S, Leray E, Jouan F, Bellaud P, et al.  Plasma level and tissue expression of vascular endothelial growth factor in renal cell carcinoma: a prospective study of 50 cases. Hum Pathol. 2007;38(10):1489\u201395.  http://dx.doi.org/10.1016/j.humpath.2007.02.014.", "ArticleIdList": ["10.1016/j.humpath.2007.02.014", "17597181"]}, {"Citation": "Lin CC, Huang CY, Mong MC, Chan CY, Yin MC. Antiangiogenic Potential of Three Triterpenic Acids in Human Liver Cancer Cells. J Agric Food Chem. 2011;59(2):755\u201362.  http://dx.doi.org/10.1021/jf103904b.", "ArticleIdList": ["10.1021/jf103904b", "21175131"]}, {"Citation": "Ovesn\u00e1 Z, Vach\u00e1lkov\u00e1 A, Horv\u00e1thov\u00e1 K, T\u00f3thov\u00e1 D. Pentacyclic triterpenoic acids: new chemoprotective compounds. Minireview. Neoplasma. 2004;51(5):327\u201333.", "ArticleIdList": ["15640935"]}, {"Citation": "Sohn KH, Lee HY, Chung HY, Young HS, Yi SY, Kim KW. Anti-angiogenic activity of triterpene acids. Cancer Lett. 1995 Aug 1;94(2):213\u20138.  http://dx.doi.org/10.1016/0304-3835(95)03856-R.", "ArticleIdList": ["10.1016/0304-3835(95)03856-R", "7543366"]}, {"Citation": "Sogno I, Vannini N, Lorusso G, Cammarota R, Noonan DM, Generoso L, et al. Anti-angiogenic activity of a novel class of chemopreventive compounds: oleanic acid terpenoids. Recent Results Cancer Res. 2009;181:209\u201312.", "ArticleIdList": ["19213570"]}, {"Citation": "Staunton MJ, Gaffney EF. Tumor type is a determinant of susceptibility to apoptosis. Am J Clin Pathol. 1995;103(3):300\u20137.  http://dx.doi.org/10.1093/ajcp/103.3.300.", "ArticleIdList": ["10.1093/ajcp/103.3.300", "7872252"]}, {"Citation": "Qazi AK, Hussain A, Aga MA, Ali S, Taneja SC, Sharma PR, et al.  Cell specific apoptosis by RLX is mediated by NF\u03baB in human colon carcinoma HCT-116 cells. BMC Cell Biol. 2014;15:36.  http://dx.doi.org/10.1186/1471-2121-15-36.", "ArticleIdList": ["10.1186/1471-2121-15-36", "PMC4195704", "25303828"]}]}], "History": [{"Year": "2017", "Month": "2", "Day": "12"}, {"Year": "2017", "Month": "2", "Day": "27"}, {"Year": "2017", "Month": "4", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "4", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "4", "Day": "14", "Hour": "6", "Minute": "1"}, {"Year": "2017", "Month": "3", "Day": "21"}], "PublicationStatus": "epublish", "ArticleIdList": ["28405545", "PMC5364332", "10.15586/jkcvhl.2017.64", "040103"]}}]}